The selectivity of α‐adrenoceptor agonists for the human α1A, α1B, and α1D‐adrenoceptors
Abstract Highly selective drugs offer a way to minimize side‐effects. For agonist ligands, this could be through highly selective affinity or highly selective efficacy, but this requires careful measurements of intrinsic efficacy. The α1‐adrenoceptors are important clinical targets, and α1‐agonists...
Main Authors: | Richard G. W. Proudman, Jillian G. Baker |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | Pharmacology Research & Perspectives |
Subjects: | |
Online Access: | https://doi.org/10.1002/prp2.799 |
Similar Items
-
The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors
by: Richard G. W. Proudman, et al.
Published: (2020-08-01) -
α1- and α2-Adrenoceptors in the Eye : Pharmacological and Functional Characterization
by: Wikberg-Matsson, Anna
Published: (2001) -
The α2-Adrenoceptor Agonist Dexmedetomidine in Current Sedation Practice
by: I. A. Kozlov
Published: (2013-04-01) -
First Direct Isolation of Stable α-Form Crystals of Mirabegron, a Selective β3–Adrenoceptor Agonist
by: Vijayavitthal T. Mathad, et al.
Published: (2017-06-01) -
Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer
by: Meredith Mihalopoulos, et al.
Published: (2020-08-01)